ResearcherUniversity Health NetworkActive in the last 2 years

Camilla Zimmermann

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4889-0244; OpenAlex author ID A5055774990. Sources: ClinicalTrials.gov.

Their work

Papers: 2
Trials: 4 (principal investigator on 4)
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper · 2016: 1 trial · 2017: none · 2018: none · 2019: 1 paper, 1 trial · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 trial · 2026: 1 trial

Papers 2

Trials 4

STEP2 vs. Routine Early Palliative Care: Randomized Noninferiority Trial Principal investigator NCT07446660 ↗
Pilot Trial of Virtual and In-person STEP2 Principal investigator NCT06326554 ↗
Symptom Screening With Targeted Early Palliative Care (STEP) Versus Usual Care for Patients With Advanced Cancer Principal investigator NCT03987906 ↗
Symptom Screening With Targeted Early Palliative Care (STEP) for Patients With Advanced Cancer Principal investigator NCT04044040 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gary Rodin · 1 shared paper, 2019 · strength 0.09
- Paper Development of a psychoeducational intervention for people affected by pancreatic cancer. DOI 10.1186/s40814-019-0466-x ↗
Eryn Tong · 1 shared paper, 2019 · strength 0.09
- Paper Development of a psychoeducational intervention for people affected by pancreatic cancer. DOI 10.1186/s40814-019-0466-x ↗
Steve Gallinger · 1 shared paper, 2019 · strength 0.09
- Paper Development of a psychoeducational intervention for people affected by pancreatic cancer. DOI 10.1186/s40814-019-0466-x ↗
Shabbir M.H. Alibhai · 1 shared paper, 2015 · strength 0.06
- Paper Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. DOI 10.1093/jnci/dju424 ↗
Raymond Jang · 1 shared paper, 2015 · strength 0.06
- Paper Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. DOI 10.1093/jnci/dju424 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.